Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21.

Hernández-Walias FJ, Vázquez E, Pacheco Y, Rodríguez-Fernández JM, Pérez-Elías MJ, Dronda F, Casado JL, Moreno A, Hermida JM, Quereda C, Hernando A, Tejerina-Picado F, Asensi V, Galindo MJ, Leal M, Moreno S, Vallejo A.

J Clin Med. 2020 Mar 11;9(3). pii: E760. doi: 10.3390/jcm9030760.

2.

Factors associated with sepsis development in 606 Spanish adult patients with cellulitis.

Collazos J, de la Fuente B, de la Fuente J, García A, Gómez H, Menéndez C, Enríquez H, Sánchez P, Alonso M, López-Cruz I, Martín-Regidor M, Martínez-Alonso A, Guerra J, Artero A, Blanes M, Asensi V.

BMC Infect Dis. 2020 Mar 12;20(1):211. doi: 10.1186/s12879-020-4915-1.

3.

Tudor military surgery and the management of Sir Martin Frobisher's gunshot wound: Comparison with current treatment.

Asensi V, Perciaccante A, Lippi D, Charlier P, Appenzeller O, Bianucci R, Donell S.

Injury. 2020 Feb 1. pii: S0020-1383(20)30074-7. doi: 10.1016/j.injury.2020.01.046. [Epub ahead of print] Review.

PMID:
32044118
4.

Ethambutol-resistant Mycobacterium kansasii cervical lymphadenitis in an immunocompetent adult patient: A case report and literature review.

Asensi V, Palacios JJ, Rivas-Carmenado M, Suárez-Zarracina T, Garcia-Carus E, Fernández LM, Torres HE, Fierer J, Carton JA.

J Clin Tuberc Other Mycobact Dis. 2019 Dec 6;18:100137. doi: 10.1016/j.jctube.2019.100137. eCollection 2020 Feb.

5.

Unilateral cryptorchidism in a 16th Florentine painting.

Lippi D, Masieri L, Perciaccante A, Charlier P, Asensi V, Appenzeller O, Bianucci R.

J Matern Fetal Neonatal Med. 2019 Dec 3:1-3. doi: 10.1080/14767058.2019.1698542. [Epub ahead of print] No abstract available.

PMID:
31795781
6.

The N125S polymorphism in the cathepsin G gene (rs45567233) is associated with susceptibility to osteomyelitis in a Spanish population.

Pérez-Is L, Ocaña MG, Montes AH, Carton JA, Álvarez V, Meana Á, Fierer J, Valle-Garay E, Asensi V.

PLoS One. 2019 Oct 24;14(10):e0220022. doi: 10.1371/journal.pone.0220022. eCollection 2019.

7.

Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors.

Alejos B, Suárez-García I, Bisbal O, Iribarren JA, Asensi V, Górgolas M, Muga R, Moreno S, Jarrín I; CoRIS cohort.

PLoS One. 2019 Aug 26;14(8):e0221598. doi: 10.1371/journal.pone.0221598. eCollection 2019.

8.

Goebbels´ clubfoot: a case of osteomyelitis?

Asensi V, Charlier P, Lippi D, Brisard JC, Appenzeller O, Bianucci R.

Intern Emerg Med. 2019 Aug;14(5):813-815. doi: 10.1007/s11739-019-02109-0. Epub 2019 May 20. No abstract available.

PMID:
31111421
9.

Open Tension Pneumothorax in "The Dying Niobid" (Uffizi Gallery).

Lippi D, Perciaccante A, Asensi V, Charlier P, Appenzeller O, Bianucci R.

Chest. 2019 Apr;155(4):878-880. doi: 10.1016/j.chest.2018.12.028. No abstract available.

PMID:
30955578
10.

Nonmelanoma skin cancer killed Mattia Preti (1613-1699), the "Calabrian Knight".

Perciaccante A, Lippi D, Asensi V, Coralli A, Charlier P, Appenzeller O, Bianucci R.

Med Hypotheses. 2019 Apr;125:124-125. doi: 10.1016/j.mehy.2019.02.045. Epub 2019 Feb 26. No abstract available.

PMID:
30902139
11.

Risk of cancer in HIV-infected patients in Spain, 2004-2015. The CoRIS cohort study.

García-Abellán J, Del Río L, García JA, Padilla S, Vivancos MJ, Del Romero J, Asensi V, Hernando A, García-Fraile L, Masiá M, Gutiérrez F; la Cohorte de la Red Nacional de Sida (CoRIS).

Enferm Infecc Microbiol Clin. 2019 Oct;37(8):502-508. doi: 10.1016/j.eimc.2018.11.011. Epub 2019 Jan 22. English, Spanish.

PMID:
30679001
12.

Evidence of hypothyroidism in a portrait by Lorenzo Lotto.

Asensi V, Lippi D, Perciaccante A, Charlier P, Appenzeller O, Bianucci R.

Lancet Diabetes Endocrinol. 2019 Jan;7(1):14. doi: 10.1016/S2213-8587(18)30342-5. No abstract available.

PMID:
30577890
13.

Factors predictive of relapse in adult bacterial osteomyelitis of long bones.

Garcia Del Pozo E, Collazos J, Carton JA, Camporro D, Asensi V.

BMC Infect Dis. 2018 Dec 7;18(1):635. doi: 10.1186/s12879-018-3550-6.

14.

Cellulitis in adult patients: A large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment.

Collazos J, de la Fuente B, García A, Gómez H, Menéndez C, Enríquez H, Sánchez P, Alonso M, López-Cruz I, Martín-Regidor M, Martínez-Alonso A, Guerra J, Artero A, Blanes M, de la Fuente J, Asensi V.

PLoS One. 2018 Sep 27;13(9):e0204036. doi: 10.1371/journal.pone.0204036. eCollection 2018.

15.

Bacterial osteomyelitis: microbiological, clinical, therapeutic, and evolutive characteristics of 344 episodes.

García Del Pozo E, Collazos J, Cartón JA, Camporro D, Asensi V.

Rev Esp Quimioter. 2018 Jun;31(3):217-225. Epub 2018 May 11.

16.

Decreasing rates of acute myocardial infarction in people living with HIV: a nationwide cohort study in Spain, 2004-2015.

Masiá M, Padilla S, García JA, Bernardino JI, Campins AA, Asensi V, Gutiérrez F; Cohort of HIV Adults of the AIDS Research Network (CoRIS) study.

HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12616. [Epub ahead of print]

PMID:
29683252
17.

Malthus Mysterious Orofacial Cleft Correction.

Diaz M, Llorente M, Asensi V.

Cleft Palate Craniofac J. 2018 Nov;55(10):1456-1457. doi: 10.1177/1055665618760411. Epub 2018 Mar 14.

PMID:
29537879
18.

Pyoderma gangrenosum and primary cutaneous cryptococcosis in an ulcerative colitis patient.

Fraile López M, de Francisco R, Pérez-Martínez I, García García B, Vivanco Allende B, Asensi V, Riestra S.

Gastroenterol Hepatol. 2019 Feb;42(2):107-108. doi: 10.1016/j.gastrohep.2018.01.012. Epub 2018 Mar 5. English, Spanish. No abstract available.

PMID:
29519678
19.

A fatal case of Babesia divergens infection in Northwestern Spain.

Asensi V, González LM, Fernández-Suárez J, Sevilla E, Navascués RÁ, Suárez ML, Lauret ME, Bernardo A, Carton JA, Montero E.

Ticks Tick Borne Dis. 2018 Mar;9(3):730-734. doi: 10.1016/j.ttbdis.2018.02.018. Epub 2018 Feb 21.

PMID:
29496491
20.

Expression profiling of chromatin-modifying enzymes and global DNA methylation in CD4+ T cells from patients with chronic HIV infection at different HIV control and progression states.

Bogoi RN, de Pablo A, Valencia E, Martín-Carbonero L, Moreno V, Vilchez-Rueda HH, Asensi V, Rodriguez R, Toledano V, Rodés B.

Clin Epigenetics. 2018 Feb 13;10:20. doi: 10.1186/s13148-018-0448-5. eCollection 2018.

21.

Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients.

Collazos J, Valle-Garay E, Suárez-Zarracina T, Montes AH, Cartón JA, Asensi V.

World J Virol. 2017 May 12;6(2):36-45. doi: 10.5501/wjv.v6.i2.36.

22.

Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Asensi V, Crespo M, Domingo P, Iribarren JA, Lázaro P, López-Aldeguer J, Lozano F, Martínez E, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, Santos J, de la Torre J, Tuset M, Gatell JM.

Enferm Infecc Microbiol Clin. 2018 May;36(5):268-276. doi: 10.1016/j.eimc.2017.04.002. Epub 2017 May 19. English, Spanish.

PMID:
28532596
23.

La Tour's hypovitaminosis in the peasants' swollen eyelids and deformed nails.

Asensi V, Fierer J.

Br J Gen Pract. 2016 Dec;66(653):618. No abstract available.

24.

Overall and cause-specific excess mortality in HIV-positive persons compared with the general population: Role of HCV coinfection.

Alejos B, Hernando V, Iribarren J, Gonzalez-García J, Hernando A, Santos J, Asensi V, Gomez-Berrocal A, Del Amo J, Jarrin I; CoRIS (Cohort of the Spanish Network on HIVAIDS Research).

Medicine (Baltimore). 2016 Sep;95(36):e4727. doi: 10.1097/MD.0000000000004727.

25.

Saint Anthony's Fire.

Asensi V, Asensi JM.

JAMA Dermatol. 2016 Jul 1;152(7):850. doi: 10.1001/jamadermatol.2015.5476. No abstract available.

PMID:
27409055
26.

Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir.

Rojas J, Lonca M, Imaz A, Estrada V, Asensi V, Miralles C, Domingo P, Montero M, del Rio L, Fontdevila J, Perez I, Cruceta A, Gatell JM, Arnedo M, Martínez E.

HIV Med. 2016 May;17(5):340-9. doi: 10.1111/hiv.12314. Epub 2015 Sep 10.

27.

Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013.

Sobrino-Vegas P, Moreno S, Rubio R, Viciana P, Bernardino JI, Blanco JR, Bernal E, Asensi V, Pulido F, del Amo J, Hernando V; Cohorte de la Red de Investigación en Sida, Spain.

J Infect. 2016 May;72(5):587-96. doi: 10.1016/j.jinf.2016.01.017. Epub 2016 Feb 24.

28.

Factors associated with long-term CD4 cell recovery in HIV-infected patients on successful antiretroviral therapy.

Collazos J, Valle-Garay E, Carton JA, Montes AH, Suarez-Zarracina T, De la Fuente B, Asensi V.

HIV Med. 2016 Aug;17(7):532-41. doi: 10.1111/hiv.12354. Epub 2016 Jan 11.

29.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ; SPREAD Program, Puchhammer-Stockl E, Sarcletti M, Schmied B, Geit M, Balluch G, Vandamme AM, Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, Vandekerckhove LPR, Van den Heuvel A, Van Der Gucht B, Van Ranst M, Van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Van Laethem K, Beshkov D, Alexiev I, Lepej SZ, Begovac J, Kostrikis L, Demetriades I, Kousiappa I, Demetriou V, Hezka J, Linka M, Maly M, Machala L, Nielsen C, Jørgensen LB, Gerstoft J, Mathiesen L, Pedersen C, Nielsen H, Laursen A, Kvinesdal B, Liitsola K, Ristola M, Suni J, Sutinen J, Descamps D, Assoumou L, Castor G, Grude M, Flandre P, Storto A, Hamouda O, Kücherer C, Berg T, Braun P, Poggensee G, Däumer M, Eberle J, Heiken H, Kaiser R, Knechten H, Korn K, Müller H, Neifer S, Schmidt B, Walter H, Gunsenheimer-Bartmeyer B, Harrer T, Paraskevis D, Hatzakis A, Zavitsanou A, Vassilakis A, Lazanas M, Chini M, Lioni A, Sakka V, Kourkounti S, Paparizos V, Antoniadou A, Papadopoulos A, Poulakou G, Katsarolis I, Protopapas K, Chryssos G, Drimis S, Gargalianos P, Xylomenos G, Lourida G, Psichogiou M, Daikos GL, Sipsas NV, Kontos A, Gamaletsou MN, Koratzanis G, Sambatakou H, Mariolis H, Skoutelis A, Papastamopoulos V, Georgiou O, Panagopoulos P, Maltezos E, Coughlan S, De Gascun C, Byrne C, Duffy M, Bergin C, Reidy D, Farrell G, Lambert J, O'Connor E, Rochford A, Low J, Coakely P, O'Dea S, Hall W, Mor O, Levi I, Chemtob D, Grossman Z, Zazzi M, de Luca A, Balotta C, Riva C, Mussini C, Caramma I, Capetti A, Colombo MC, Rossi C, Prati F, Tramuto F, Vitale F, Ciccozzi M, Angarano G, Rezza G, Kolupajeva T, Vasins O, Griskevicius A, Lipnickiene V, Schmit JC, Struck D, Sauvageot N, Hemmer R, Arendt V, Michaux C, Staub T, Sequin-Devaux C, Wensing AMJ, Boucher CAB, van de Vijver DAMC, van Kessel A, van Bentum PHM, Brinkman K, Connell BJ, van der Ende ME, Hoepelman IM, van Kasteren M, Kuipers M, Langebeek N, Richter C, Santegoets RMWJ, Schrijnders-Gudde L, Schuurman R, van de Ven BJM, Åsjö B, Kran AB, Ormaasen V, Aavitsland P, Horban A, Stanczak JJ, Stanczak GP, Firlag-Burkacka E, Wiercinska-Drapalo A, Jablonowska E, Maolepsza E, Leszczyszyn-Pynka M, Szata W, Camacho R, Palma C, Borges F, Paixão T, Duque V, Araújo F, Otelea D, Paraschiv S, Tudor AM, Cernat R, Chiriac C, Dumitrescu F, Prisecariu LJ, Stanojevic M, Jevtovic D, Salemovic D, Stanekova D, Habekova M, Chabadová Z, Drobkova T, Bukovinova P, Shunnar A, Truska P, Poljak M, Lunar M, Babic D, Tomazic J, Vidmar L, Vovko T, Karner P, Garcia F, Paredes R, Monge S, Moreno S, Del Amo J, Asensi V, Sirvent JL, de Mendoza C, Delgado R, Gutiérrez F, Berenguer J, Garcia-Bujalance S, Stella N, de Los Santos I, Blanco JR, Dalmau D, Rivero M, Segura F, Elías MJP, Alvarez M, Chueca N, Rodríguez-Martín C, Vidal C, Palomares JC, Viciana I, Viciana P, Cordoba J, Aguilera A, Domingo P, Galindo MJ, Miralles C, Del Pozo MA, Ribera E, Iribarren JA, Ruiz L, de la Torre J, Vidal F, Clotet B, Albert J, Heidarian A, Aperia-Peipke K, Axelsson M, Mild M, Karlsson A, Sönnerborg A, Thalme A, Navér L, Bratt G, Karlsson A, Blaxhult A, Gisslén M, Svennerholm B, Bergbrant I, Björkman P, Säll C, Mellgren Å, Lindholm A, Kuylenstierna N, Montelius R, Azimi F, Johansson B, Carlsson M, Johansson E, Ljungberg B, Ekvall H, Strand A, Mäkitalo S, Öberg S, Holmblad P, Höfer M, Holmberg H, Josefson P, Ryding U.

Clin Infect Dis. 2016 Mar 1;62(5):655-663. doi: 10.1093/cid/civ963. Epub 2015 Nov 29.

30.

Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics.

Asensi V, Collazos J, Valle-Garay E.

World J Virol. 2015 Aug 12;4(3):169-77. doi: 10.5501/wjv.v4.i3.169.

31.

The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions.

Collazos J, Asensi V, Martin G, Montes AH, Suárez-Zarracina T, Valle-Garay E.

Clin Exp Immunol. 2015 Nov;182(2):213-9. doi: 10.1111/cei.12686. Epub 2015 Sep 11.

32.

CD4⁺CD28null T lymphocytes resemble CD8⁺CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients.

Echeverría A, Moro-García MA, Asensi V, Cartón JA, López-Larrea C, Alonso-Arias R.

J Leukoc Biol. 2015 Sep;98(3):373-84. doi: 10.1189/jlb.1A0514-276RR. Epub 2015 Jun 1.

PMID:
26034206
33.

HIV/antiretroviral therapy-related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasma.

Peraire J, López-Dupla M, Alba V, Beltrán-Debón R, Martinez E, Domingo P, Asensi V, Leal M, Viladés C, Inza MI, Escoté X, Arnedo M, Mateo G, Valle-Garay E, Ferrando-Martinez S, Veloso S, Vendrell J, Gatell JM, Vidal F; HIV-1 Lipodystrophy Study Group.

Clin Microbiol Infect. 2015 Jul;21(7):711.e1-8. doi: 10.1016/j.cmi.2015.04.002. Epub 2015 Apr 14.

34.

Endothelial (NOS3 E298D) and inducible (NOS2 exon 22) nitric oxide synthase polymorphisms, as well as plasma NOx, influence sepsis development.

Martin G, Asensi V, Montes AH, Collazos J, Alvarez V, Pérez-Is L, Carton JA, Taboada F, Valle-Garay E.

Nitric Oxide. 2014 Nov 15;42:79-86. doi: 10.1016/j.niox.2014.09.004. Epub 2014 Sep 16.

PMID:
25239655
35.

[Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus].

Grupo de expertos del Grupo de Estudio sobre Alteraciones Metabólicas (GEAM), de la Secretaría del Plan Nacional sobre el Sida (SPNS) y del Grupo de Estudio de Sida (GeSIDA), Polo Rodríguez R, Galindo Puerto MJ, Dueñas C, Gómez Candela C, Estrada V, Villar NG, Locutura J, Mariño A, Pascua J, Palacios R, von Wichmman MÁ, Álvarez J, Asensi V, Lopez Aldeguer J, Lozano F, Negredo E, Ortega E, Pedrol E, Gutiérrez F, Sanz Sanz J, Martínez Chamorro E.

Enferm Infecc Microbiol Clin. 2015 Jan;33(1):40.e1-40.e16. doi: 10.1016/j.eimc.2014.06.006. Epub 2014 Aug 28. Spanish.

PMID:
25176009
36.

Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection.

Panel of experts from the Metabolic Disorders Study Group (GEAM), National Aids Plan (SPNS), Aids Study Group (GeSIDA), Polo Rodríguez R, Galindo Puerto MJ, Dueñas C, Gómez Candela C, Estrada V, Villar NG, Locutura J, Mariño A, Pascua J, Palacios R, Von Wichmman MÁ, Álvarez J, Asensi V, Lopez Aldeguer J, Lozano F, Negredo E, Ortega E, Pedrol E, Gutiérrez F, Sanz Sanz J, Martínez Chamorro E.

Enferm Infecc Microbiol Clin. 2015 Jan;33(1):41-7. doi: 10.1016/j.eimc.2014.05.018. Epub 2014 Aug 3.

PMID:
25096166
37.

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).

Expert Panel of GeSIDA and the National Aids Plan, Berenguer J, Polo R, Lozano F, López Aldeguer J, Antela A, Arribas JR, Asensi V, Blanco JR, Clotet B, Domingo P, Galindo MJ, Gatell JM, González-García J, Iribarren JA, Locutura J, López JC, Mallolas J, Martínez E, Miralles C, Miró JM, Moreno S, Palacios R, Pérez Elías MJ, Pineda JA, Podzamczer D, Portilla J, Pulido F, Ribera E, Riera M, Rubio R, Santos J, Sanz J, Tuset M, Vidal F, Rivero A.

Enferm Infecc Microbiol Clin. 2014 Aug-Sep;32(7):447-58. doi: 10.1016/j.eimc.2014.02.018. Epub 2014 Jun 28.

PMID:
24986715
38.

Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients.

Podzamczer D, Imaz A, Perez I, Viciana P, Valencia E, Curto J, Martín T, Castaño M, Rojas J, Espinosa N, Moreno V, Asensi V, Iribarren JA, Clotet B, Force L, Bachiller P, Knobel H, López Bernaldo De Quirós JC, Blanco JR, Rozas N, Vergas J, Ocampo A, Camacho A, Flores J, Gomez-Sirvent JL; KIDAR Study Group.

J Antimicrob Chemother. 2014 Sep;69(9):2536-40. doi: 10.1093/jac/dku157. Epub 2014 May 15.

PMID:
24833755
39.

Role of plasma matrix-metalloproteases (MMPs) and their polymorphisms (SNPs) in sepsis development and outcome in ICU patients.

Martin G, Asensi V, Montes AH, Collazos J, Alvarez V, Carton JA, Taboada F, Valle-Garay E.

Sci Rep. 2014 May 16;4:5002. doi: 10.1038/srep05002.

40.

Immune reconstitution inflammatory syndrome-Unmasking endophthalmic, lymphadenopathic, and neuromeningeal cryptococcosis in an HIV-infected patient starting highly active antiretroviral therapy.

Martinez-Zapico A, Asensi V, Fuentes N, Fonollá M, Rodriguez M, Cárcaba V, Carton JA.

AIDS Res Hum Retroviruses. 2014 May;30(5):434-5. doi: 10.1089/AID.2014.0039. No abstract available.

PMID:
24724818
41.

Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS).

Viladés C, Escoté X, López-Dupla M, Martinez E, Domingo P, Asensi V, Leal M, Peraire J, Inza MI, Arnedo M, Gutiérrez M, Valle-Garay E, Ferrando-Martinez S, Olona M, Alba V, Sirvent JJ, Gatell JM, Vidal F; HALS Study Group.

J Antimicrob Chemother. 2014 Jun;69(6):1653-9. doi: 10.1093/jac/dku032. Epub 2014 Feb 16.

PMID:
24535275
42.

Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs.

Gutiérrez F, García L, Padilla S, Alvarez D, Moreno S, Navarro G, Gómez-Sirvent J, Vidal F, Asensi V, Masiá M; CoRIS.

HIV Med. 2014 Apr;15(4):213-23. doi: 10.1111/hiv.12104. Epub 2013 Nov 11.

43.

Efficacy and tolerability of darunavir/ritonavir in combination with abacavir/lamivudine: an option in selected HIV-infected patients.

de los Santos I, Gómez-Berrocal A, Valencia E, Asensi V, Gijón P, Moreno V, Vergas J, Bernardino I.

HIV Clin Trials. 2013 Sep-Oct;14(5):254-9. doi: 10.1310/hct1405-254.

PMID:
24144901
44.

tPA Alu (I/D) polymorphism associates with bacterial osteomyelitis.

Valle-Garay E, Montes AH, Corte JR, Meana A, Fierer J, Asensi V.

J Infect Dis. 2013 Jul 15;208(2):218-23. doi: 10.1093/infdis/jit158. Epub 2013 Apr 9.

PMID:
23570848
45.

Euler's right eye: the dark side of a bright scientist.

Asensi V, Asensi JM.

Clin Infect Dis. 2013 Jul;57(1):158-9. doi: 10.1093/cid/cit170. Epub 2013 Mar 13. No abstract available.

PMID:
23487386
46.

The effect of unsuccessful treatment with peginterferon and ribavirin on the liver fibrosis course of HIV/HCV-coinfected patients.

Collazos J, Asensi V, de la Fuente B, Cartón JA.

Curr HIV Res. 2012 Dec;10(8):679-87.

PMID:
23061599
47.

Didanosine (ddI) associates with increased liver fibrosis in adult HIV-HCV coinfected patients.

Suárez-Zarracina T, Valle-Garay E, Collazos J, Montes AH, Cárcaba V, Carton JA, Asensi V.

J Viral Hepat. 2012 Oct;19(10):685-93. doi: 10.1111/j.1365-2893.2012.01596.x. Epub 2012 Mar 15.

PMID:
22967099
48.

Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-α for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial.

Labarga P, Barreiro P, da Silva A, Guardiola JM, Rubio R, Aguirrebengoa K, Miralles P, Portu J, Téllez MJ, Morano L, Castro A, Pineda JA, Terrón A, Hernández-Quero J, Mariño A, Ríos MJ, Echeverría S, Asensi V, Vispo E, Soriano V; PERICO Study Group.

J Infect Dis. 2012 Sep 15;206(6):961-8. Epub 2012 Jul 17.

PMID:
22807523
49.

Course of liver fibrosis in HIV-hepatitis C virus-coinfected patients depending on the response to hepatitis C therapy.

Cartón JA, Collazos J, de la Fuente B, Asensi V.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):215-22. doi: 10.1089/AID.2012.0108. Epub 2012 Jul 31.

PMID:
22734850
50.

Definition of advanced age in HIV infection: looking for an age cut-off.

Blanco JR, Jarrín I, Vallejo M, Berenguer J, Solera C, Rubio R, Pulido F, Asensi V, del Amo J, Moreno S; CoRIS.

AIDS Res Hum Retroviruses. 2012 Sep;28(9):1000-6. doi: 10.1089/AID.2011.0377.

Supplemental Content

Loading ...
Support Center